Platts M M, Anastassiades E, Sheriff S, Smith S, Bartolo D C
Br Med J (Clin Res Ed). 1984 Nov 24;289(6456):1415-8. doi: 10.1136/bmj.289.6456.1415.
To investigate the cause of clinically detectable splenomegaly, which is common in patients receiving regular haemodialysis, splenic volume was assessed by isotopic scanning using intravenously injected technetium-99m microspheres in 34 controls and 149 patients with chronic renal failure. Of the patients, 16 had never received dialysis, 10 were undergoing continuous peritoneal dialysis, 94 were undergoing regular haemodialysis, and 29 had undergone successful renal transplantation more than nine months previously. Mean splenic volume was increased only in the patients who were receiving haemodialysis. Splenic enlargement was probably not due to iron overload as it occurred in all patients who had received haemodialysis, 14 of whom had not received intravenous iron. No patient had had hepatitis. Splenic enlargement was probably related to the process of haemodialysis itself and may have been due either to red cell damage produced by haemodialysis or to an immunological reaction induced by a component of haemodialysis, possibly ethylene oxide.
为了探究临床上可检测到的脾肿大的原因(脾肿大在接受定期血液透析的患者中很常见),我们使用静脉注射的锝-99m微球通过同位素扫描对34名对照者和149名慢性肾衰竭患者的脾脏体积进行了评估。在这些患者中,16名从未接受过透析,10名正在接受持续性腹膜透析,94名正在接受定期血液透析,29名在九个多月前已成功接受肾移植。仅接受血液透析的患者脾脏平均体积增大。脾肿大可能并非由铁过载所致,因为在所有接受血液透析的患者中均出现了脾肿大,其中14名患者未接受过静脉补铁。没有患者患过肝炎。脾肿大可能与血液透析过程本身有关,可能是由于血液透析导致的红细胞损伤,或者是由血液透析的一种成分(可能是环氧乙烷)引发的免疫反应。